PLATELET-LEUKOCYTE INTERACTION IN ADHESION TO ENDOTHELIAL-CELLS INDUCED BY PLATELET-ACTIVATING-FACTOR INVITRO

被引:27
作者
HIRAFUJI, M
SHINODA, H
机构
[1] Department of Pharmacology, Tohoku University School of Dentistry, Sendai, 980
关键词
PLATELET-ACTIVATING FACTOR (PAF); PLATELETS; LEUKOCYTES; ENDOTHELIAL CELLS; PLATELET ADHESION; VASCULAR INJURY;
D O I
10.1111/j.1476-5381.1991.tb09789.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Platelet-activating factor (PAF, 10 nM) did not induce platelet adhesion to endothelial cells cultured in monolayer but it induced their adhesion to protein-coated plastic. However, PAF induced a marked platelet adhesion to endothelial cells when polymorphonuclear leukocytes (PMNs) were present. Lyso-PAF had no effect. 2 Phase-contrast microscopic examination showed that single platelets rather than their aggregates adhered to the endothelial cell surface around aggregating and adhering PMNs. 3 Significant platelet adhesion was induced by PAF at concentrations higher than 0.01 nM with the maximal response at 10 nM. Platelet adhesion occurred within minutes after PAF addition, reaching a maximum approximately after 30 min. Platelet adhesion also occurred significantly at a PMN: platelet ratio of 1:800, and linearly up to 1:50. 4 The PAF-induced platelet adhesion was suppressed by three structurally unrelated PAF antagonists, WEB 2086, ONO 6240 and BN 52021, in a concentration-dependent manner. 5 PAF also increased PMN adhesion to endothelial cell monolayers, which was further augmented by the presence of platelets. 6 The present study demonstrates that PAF induces platelet adhesion to endothelial cells in vitro when PMNs are present and that there is a close interaction between platelets and PMNs in their adhesion to endothelial cells. The present study further suggests that PMNs could play a central role in platelet adhesion to vascular endothlium in certain pathological conditions.
引用
收藏
页码:1333 / 1338
页数:6
相关论文
共 35 条
[1]   LEUKOCYTE-DEPENDENT HISTAMINE-RELEASE FROM RABBIT PLATELETS - ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR [J].
BENVENISTE, J ;
HENSON, PM ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1356-+
[2]   ENHANCEMENT OF GRANULOCYTE ENDOTHELIAL-CELL ADHERENCE AND GRANULOCYTE-INDUCED CYTO-TOXICITY BY PLATELET-RELEASE PRODUCTS [J].
BOOGAERTS, MA ;
YAMADA, O ;
JACOB, HS ;
MOLDOW, CF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (22) :7019-7023
[3]  
BOURGAIN RH, 1984, ADV EXP MED BIOL, V180, P635
[4]  
Braquet P., 1985, BLOOD VESSELS, V16, P559
[5]  
BREVIARIO F, 1988, J IMMUNOL, V141, P3391
[6]  
BUCHANAN MR, 1985, J BIOL CHEM, V260, P6056
[7]  
BUSSOLINO F, 1987, J IMMUNOL, V139, P2439
[8]  
CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974
[9]   DIRECT EVIDENCE FOR THE EXISTENCE OF A NEUTROPHIL-DERIVED PLATELET ACTIVATOR (NEUTROPHILIN) [J].
CHIGNARD, M ;
SELAK, MA ;
SMITH, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8609-8613
[10]  
CLARK RA, 1980, J IMMUNOL, V124, P399